The need for targeted, effective therapeutic treatments for central nervous system (CNS) disorders has never been greater, due in part to improved diagnosis rates and an aging population that brings a higher incidence of debilitating neurodegenerative diseases such as Alzheimer's and Parkinson's diseases.